{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:40:46Z","timestamp":1792708846413,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016156","name":"U.S. Army Medical Research and Development Command","doi-asserted-by":"crossref","award":["W81XWH-14-2-0134"],"award-info":[{"award-number":["W81XWH-14-2-0134"]}],"id":[{"id":"10.13039\/100016156","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016156","name":"U.S. Army Medical Research and Development Command","doi-asserted-by":"crossref","award":["W81XWH-20-C-0031"],"award-info":[{"award-number":["W81XWH-20-C-0031"]}],"id":[{"id":"10.13039\/100016156","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AI007417"],"award-info":[{"award-number":["T32 AI007417"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011780","name":"Johns Hopkins | Bloomberg School of Public Health | Johns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI125534"],"award-info":[{"award-number":["R01AI125534"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016156","name":"U.S. Army Medical Research and Development Command","doi-asserted-by":"crossref","award":["W81XWH-15-C-0061"],"award-info":[{"award-number":["W81XWH-15-C-0061"]}],"id":[{"id":"10.13039\/100016156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Due to the recurring loss of antimalarial drugs to resistance, there is a need for novel targets, drugs, and combination therapies to ensure the availability of current and future countermeasures. Pyrazoleamides belong to a novel class of antimalarial drugs that disrupt sodium ion homeostasis, although the exact consequences of this disruption in <jats:italic>Plasmodium falciparum<\/jats:italic> remain under investigation. In vitro experiments demonstrated that parasites carrying mutations in the metabolic enzyme PfATP4 develop resistance to pyrazoleamide compounds. However, the underlying mechanisms that allow mutant parasites to evade pyrazoleamide treatment are unclear. Here, we first performed experiments to identify the sublethal dose of a pyrazoleamide compound (PA21A092) that caused a significant reduction in growth over one intraerythrocytic developmental cycle (IDC). At this drug concentration, we collected transcriptomic and metabolomic data at multiple time points during the IDC to quantify gene- and metabolite-level alterations in the treated parasites. To probe the effects of pyrazoleamide treatment on parasite metabolism, we coupled the time-resolved omics data with a metabolic network model of <jats:italic>P. falciparum<\/jats:italic>. We found that the drug-treated parasites adjusted carbohydrate metabolism to enhance synthesis of myoinositol\u2014a precursor for phosphatidylinositol biosynthesis. This metabolic adaptation caused a decrease in metabolite flux through the pentose phosphate pathway, causing a decreased rate of RNA synthesis and an increase in oxidative stress. Our model analyses suggest that downstream consequences of enhanced myoinositol synthesis may underlie adjustments that could lead to resistance emergence in <jats:italic>P. falciparum<\/jats:italic> exposed to a sublethal dose of a pyrazoleamide drug.<\/jats:p>","DOI":"10.1038\/s41598-022-04985-7","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T11:02:41Z","timestamp":1642762961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Metabolic adjustments of blood-stage Plasmodium falciparum in response to sublethal pyrazoleamide exposure"],"prefix":"10.1038","volume":"12","author":[{"given":"Shivendra G.","family":"Tewari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubayet","family":"Elahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krithika","family":"Rajaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaques","family":"Reifman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean T.","family":"Prigge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil B.","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9775-7469","authenticated-orcid":false,"given":"Anders","family":"Wallqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"4985_CR1","volume-title":"Report on Antimalarial Drug Efficacy, Resistance and Response: 10 Years of Surveillance (2010\u20132019)","author":"WHO","year":"2020","unstructured":"WHO. Report on Antimalarial Drug Efficacy, Resistance and Response: 10 Years of Surveillance (2010\u20132019) (World Health Organization, 2020)."},{"key":"4985_CR2","volume-title":"World Malaria Report 2019","author":"WHO","year":"2019","unstructured":"WHO. World Malaria Report 2019 (World Health Organization, 2019)."},{"key":"4985_CR3","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1111\/febs.14127","volume":"284","author":"AM Thu","year":"2017","unstructured":"Thu, A. M., Phyo, A. P., Landier, J., Parker, D. M. & Nosten, F. H. Combating multidrug-resistant Plasmodium falciparum malaria. FEBS J. 284, 2569\u20132578 (2017).","journal-title":"FEBS J."},{"key":"4985_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/QCO.0000000000000199","volume":"28","author":"RM Fairhurst","year":"2015","unstructured":"Fairhurst, R. M. Understanding artemisinin-resistant malaria: What a difference a year makes. Curr. Opin. Infect. Dis. 28, 417\u2013425 (2015).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"4985_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijpddr.2015.07.001","volume":"5","author":"NJ Spillman","year":"2015","unstructured":"Spillman, N. J. & Kirk, K. The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs. Int. J. Parasitol. Drugs Drug Resist. 5, 149\u2013162 (2015).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"4985_CR6","doi-asserted-by":"publisher","first-page":"e1005647","DOI":"10.1371\/journal.ppat.1005647","volume":"12","author":"S Das","year":"2016","unstructured":"Das, S. et al. Na+ influx induced by new antimalarials causes rapid alterations in the cholesterol content and morphology of Plasmodium falciparum. PLOS Pathog. 12, e1005647 (2016).","journal-title":"PLOS Pathog."},{"key":"4985_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1021\/cb500616x","volume":"10","author":"EL Flannery","year":"2015","unstructured":"Flannery, E. L. et al. Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarials. ACS Chem. Biol. 10, 413\u2013420 (2015).","journal-title":"ACS Chem. Biol."},{"key":"4985_CR8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1126\/science.1193225","volume":"329","author":"M Rottmann","year":"2010","unstructured":"Rottmann, M. et al. Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 1175\u20131180 (2010).","journal-title":"Science"},{"key":"4985_CR9","doi-asserted-by":"publisher","first-page":"E5455","DOI":"10.1073\/pnas.1414221111","volume":"111","author":"MB Jimenez-Diaz","year":"2014","unstructured":"Jimenez-Diaz, M. B. et al. (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium. Proc. Natl. Acad. Sci. U.S.A. 111, E5455\u2013E5462 (2014).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"4985_CR10","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1038\/ncomms6521","volume":"5","author":"AB Vaidya","year":"2014","unstructured":"Vaidya, A. B. et al. Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum. Nat. Commun. 5, 5521 (2014).","journal-title":"Nat. Commun."},{"key":"4985_CR11","doi-asserted-by":"publisher","first-page":"e02392","DOI":"10.1128\/AAC.02392-20","volume":"65","author":"SG Tewari","year":"2021","unstructured":"Tewari, S. G. et al. Metabolic survival adaptations of Plasmodium falciparum exposed to sublethal doses of fosmidomycin. Antimicrob. Agents Chemother. 65, e02392-e2420 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4985_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12936-019-2720-3","volume":"18","author":"SG Tewari","year":"2019","unstructured":"Tewari, S. G. et al. Short-term metabolic adjustments in Plasmodium falciparum counter hypoxanthine deprivation at the expense of long-term viability. Malar. J. 18, 86 (2019).","journal-title":"Malar. J."},{"key":"4985_CR13","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/nar\/gkj517","volume":"34","author":"M Llinas","year":"2006","unstructured":"Llinas, M., Bozdech, Z., Wong, E. D., Adai, A. T. & DeRisi, J. L. Comparative whole genome transcriptome analysis of three Plasmodium falciparum strains. Nucleic Acids Res. 34, 1166\u20131173 (2006).","journal-title":"Nucleic Acids Res."},{"key":"4985_CR14","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.biocel.2008.12.012","volume":"41","author":"ND Pasternak","year":"2009","unstructured":"Pasternak, N. D. & Dzikowski, R. PfEMP1: An antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite Plasmodium falciparum. Int. J. Biochem. Cell Biol. 41, 1463\u20131466 (2009).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"4985_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S2221-1691(11)60034-8","volume":"1","author":"SR Krungkrai","year":"2011","unstructured":"Krungkrai, S. R. & Krungkrai, J. Malaria parasite carbonic anhydrase: Inhibition of aromatic\/heterocyclic sulfonamides and its therapeutic potential. Asian Pac. J. Trop. Biomed. 1, 233\u2013242 (2011).","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"4985_CR16","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/j.1365-2958.2006.05325.x","volume":"61","author":"T Zeuthen","year":"2006","unstructured":"Zeuthen, T. et al. Ammonia permeability of the aquaglyceroporins from Plasmodium falciparum, Toxoplasma gondii and Trypansoma brucei. Mol. Microbiol. 61, 1598\u20131608 (2006).","journal-title":"Mol. Microbiol."},{"key":"4985_CR17","volume-title":"Biochemistry","author":"JM Berg","year":"2015","unstructured":"Berg, J. M., Tymoczko, J. L., Gatto, G. J. Jr. & Stryer, L. Biochemistry 8th edn. (W. H. Freeman, 2015).","edition":"8"},{"key":"4985_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pt.2015.10.003","volume":"32","author":"H Ginsburg","year":"2016","unstructured":"Ginsburg, H. & Abdel-Haleem, A. M. Malaria parasite metabolic pathways (MPMP) upgraded with targeted chemical compounds. Trends Parasitol. 32, 7\u20139 (2016).","journal-title":"Trends Parasitol."},{"key":"4985_CR19","doi-asserted-by":"publisher","first-page":"e1008316","DOI":"10.1371\/journal.ppat.1008316","volume":"16","author":"RP Swift","year":"2020","unstructured":"Swift, R. P. et al. A mevalonate bypass system facilitates elucidation of plastid biology in malaria parasites. PLOS Pathog 16, e1008316 (2020).","journal-title":"PLOS Pathog"},{"key":"4985_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.pt.2020.09.003","volume":"37","author":"J Khalife","year":"2021","unstructured":"Khalife, J., Freville, A., Gnangnon, B. & Pierrot, C. The multifaceted role of protein phosphatase 1 in Plasmodium. Trends Parasitol. 37, 154\u2013164 (2021).","journal-title":"Trends Parasitol."},{"key":"4985_CR21","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1038\/s41467-020-17306-1","volume":"11","author":"AS Paul","year":"2020","unstructured":"Paul, A. S. et al. Co-option of Plasmodium falciparum PP1 for egress from host erythrocytes. Nat. Commun. 11, 3532 (2020).","journal-title":"Nat. Commun."},{"key":"4985_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12936-021-03780-5","volume":"20","author":"SG Tewari","year":"2021","unstructured":"Tewari, S. G. et al. Inter-study and time-dependent variability of metabolite abundance in cultured red blood cells. Malar. J. 20, 299 (2021).","journal-title":"Malar. J."},{"key":"4985_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/bms.1200131004","volume":"13","author":"DB Kassel","year":"1986","unstructured":"Kassel, D. B., Martin, M., Schall, W. & Sweeley, C. C. Urinary metabolites of L-threonine in type 1 diabetes determined by combined gas chromatography\/chemical ionization mass spectrometry. Biomed. Environ. Mass Spectrom. 13, 535\u2013540 (1986).","journal-title":"Biomed. Environ. Mass Spectrom."},{"key":"4985_CR24","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jpba.2009.06.007","volume":"50","author":"E Appiah-Amponsah","year":"2009","unstructured":"Appiah-Amponsah, E. et al. Identification of 4-deoxythreonic acid present in human urine using HPLC and NMR techniques. J. Pharm. Biomed. Anal. 50, 878\u2013885 (2009).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"4985_CR25","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1021\/acs.jproteome.0c00215","volume":"19","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. Comparative blood and urine metabolomics analysis of healthy elderly and young male singaporeans. J. Proteome Res. 19, 3264\u20133275 (2020).","journal-title":"J. Proteome Res."},{"key":"4985_CR26","doi-asserted-by":"publisher","first-page":"13670","DOI":"10.1038\/s41598-017-13722-4","volume":"7","author":"T Pallister","year":"2017","unstructured":"Pallister, T. et al. Hippurate as a metabolomic marker of gut microbiome diversity: Modulation by diet and relationship to metabolic syndrome. Sci. Rep. 7, 13670 (2017).","journal-title":"Sci. Rep."},{"key":"4985_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.celrep.2015.03.011","volume":"11","author":"H Ke","year":"2015","unstructured":"Ke, H. et al. Genetic investigation of tricarboxylic acid metabolism during the Plasmodium falciparum life cycle. Cell Rep. 11, 164\u2013174 (2015).","journal-title":"Cell Rep."},{"key":"4985_CR28","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/s41598-020-80658-7","volume":"11","author":"RK Sah","year":"2021","unstructured":"Sah, R. K., Pati, S., Saini, M. & Singh, S. Erythrocyte sphingosine kinase regulates intraerythrocytic development of Plasmodium falciparum. Sci. Rep. 11, 1257 (2021).","journal-title":"Sci. Rep."},{"key":"4985_CR29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nature05149","volume":"443","author":"KJ Saliba","year":"2006","unstructured":"Saliba, K. J. et al. Sodium-dependent uptake of inorganic phosphate by the intracellular malaria parasite. Nature 443, 582\u2013585 (2006).","journal-title":"Nature"},{"key":"4985_CR30","doi-asserted-by":"publisher","first-page":"e1815","DOI":"10.1371\/journal.pone.0001815","volume":"3","author":"IB Muller","year":"2008","unstructured":"Muller, I. B. et al. The assembly of the plasmodial PLP synthase complex follows a defined course. PLoS ONE 3, e1815 (2008).","journal-title":"PLoS ONE"},{"key":"4985_CR31","doi-asserted-by":"publisher","first-page":"E3278","DOI":"10.1073\/pnas.1209823109","volume":"109","author":"SE Babbitt","year":"2012","unstructured":"Babbitt, S. E. et al. Plasmodium falciparum responds to amino acid starvation by entering into a hibernatory state. Proc. Natl. Acad. Sci. U.S.A. 109, E3278\u2013E3287 (2012).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"4985_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.chom.2012.12.006","volume":"13","author":"NJ Spillman","year":"2013","unstructured":"Spillman, N. J. et al. Na+ regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials. Cell Host Microbe 13, 227\u2013237 (2013).","journal-title":"Cell Host Microbe"},{"key":"4985_CR33","doi-asserted-by":"publisher","first-page":"e00087","DOI":"10.1128\/AAC.00087-18","volume":"62","author":"ASM Dennis","year":"2018","unstructured":"Dennis, A. S. M., Lehane, A. M., Ridgway, M. C., Holleran, J. P. & Kirk, K. Cell swelling induced by the antimalarial KAE609 (cipargamin) and other PfATP4-associated antimalarials. Antimicrob. Agents Chemother. 62, e00087-e118 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4985_CR34","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.3390\/molecules24193601","volume":"24","author":"S Alven","year":"2019","unstructured":"Alven, S. & Aderibigbe, B. Combination therapy strategies for the treatment of malaria. Molecules 24, 3601 (2019).","journal-title":"Molecules"},{"key":"4985_CR35","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","volume":"395","author":"RW van der Pluijm","year":"2020","unstructured":"van der Pluijm, R. W. et al. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: A multicentre, open-label, randomised clinical trial. Lancet 395, 1345\u20131360 (2020).","journal-title":"Lancet"},{"key":"4985_CR36","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1021\/acsinfecdis.0c00724","volume":"7","author":"LB Arendse","year":"2021","unstructured":"Arendse, L. B., Wyllie, S., Chibale, K. & Gilbert, I. H. Plasmodium kinases as potential drug targets for malaria: Challenges and opportunities. ACS Infect. Dis. 7, 518\u2013534 (2021).","journal-title":"ACS Infect. Dis."},{"key":"4985_CR37","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nature14412","volume":"520","author":"A Mbengue","year":"2015","unstructured":"Mbengue, A. et al. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature 520, 683\u2013687 (2015).","journal-title":"Nature"},{"key":"4985_CR38","doi-asserted-by":"publisher","first-page":"110636","DOI":"10.1016\/j.cbpa.2019.110636","volume":"242","author":"A Ma","year":"2020","unstructured":"Ma, A. et al. Osmoregulation by the myo-inositol biosynthesis pathway in turbot Scophthalmus maximus and its regulation by anabolite and c-Myc. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 242, 110636 (2020).","journal-title":"Comp. Biochem. Physiol. A Mol. Integr. Physiol."},{"key":"4985_CR39","doi-asserted-by":"publisher","first-page":"E3290","DOI":"10.1073\/pnas.1606348113","volume":"113","author":"G Dai","year":"2016","unstructured":"Dai, G., Yu, H., Kruse, M., Traynor-Kaplan, A. & Hille, B. Osmoregulatory inositol transporter SMIT1 modulates electrical activity by adjusting PI(4,5)P2 levels. Proc. Natl. Acad. Sci. U.S.A. 113, E3290\u2013E3299 (2016).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"4985_CR40","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1203\/00006450-198911000-00024","volume":"26","author":"JH Thurston","year":"1989","unstructured":"Thurston, J. H., Sherman, W. R., Hauhart, R. E. & Kloepper, R. F. Myo-inositol: A newly identified nonnitrogenous osmoregulatory molecule in mammalian brain. Pediatr. Res. 26, 482\u2013485 (1989).","journal-title":"Pediatr. Res."},{"key":"4985_CR41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12936-020-03174-z","volume":"19","author":"SG Tewari","year":"2020","unstructured":"Tewari, S. G., Swift, R. P., Reifman, J., Prigge, S. T. & Wallqvist, A. Metabolic alterations in the erythrocyte during blood-stage development of the malaria parasite. Malar. J. 19, 94 (2020).","journal-title":"Malar. J."},{"key":"4985_CR42","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41596-018-0098-2","volume":"14","author":"L Heirendt","year":"2019","unstructured":"Heirendt, L. et al. Creation and analysis of biochemical constraint-based models using the COBRA Toolbox vol 3.0. Nat. Protoc. 14, 639\u2013702 (2019).","journal-title":"Nat. Protoc."},{"key":"4985_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.12688\/wellcomeopenres.11896.2","volume":"2","author":"T Sanderson","year":"2017","unstructured":"Sanderson, T. & Rayner, J. C. PhenoPlasm: A database of disruption phenotypes for malaria parasite genes. Wellcome Open Res. 2, 45 (2017).","journal-title":"Wellcome Open Res."},{"key":"4985_CR44","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijpddr.2017.03.004","volume":"7","author":"SG Tewari","year":"2017","unstructured":"Tewari, S. G., Prigge, S. T., Reifman, J. & Wallqvist, A. Using a genome-scale metabolic network model to elucidate the mechanism of chloroquine action in Plasmodium falciparum. Int. J. Parasitol. Drugs Drug Resist. 7, 138\u2013146 (2017).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04985-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04985-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04985-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T21:30:29Z","timestamp":1669325429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04985-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4985"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-04985-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"23 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1167"}}